Literature DB >> 3518704

Elastinolytic activity of human cathepsin L.

R W Mason, D A Johnson, A J Barrett, H A Chapman.   

Abstract

The hydrolysis of a tritiated elastin substrate by the human cysteine proteinases cathepsins B and L has been studied. Cathepsin L was found to be at least 100-fold more active on this substrate than cathepsin B. The specific activity of cathepsin L at pH 5.5 for hydrolysis of elastin was about the same as that of pig pancreatic elastase at its optimum pH of 8.8.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518704      PMCID: PMC1153120          DOI: 10.1042/bj2330925

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  p-Nitrophenyl-p'-guanidinobenzoate HCl: a new active site titrant for trypsin.

Authors:  T Chase; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1967-11-30       Impact factor: 3.575

2.  Human lysosomal elastase. Catalytic and immunological properties.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1976-05-01       Impact factor: 3.857

3.  Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages.

Authors:  H A Chapman; O L Stone
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.

Authors:  H Kirschke; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

6.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

7.  Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors.

Authors:  H A Chapman; O L Stone
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Calpain inhibition by peptide epoxides.

Authors:  C Parkes; A A Kembhavi; A J Barrett
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

9.  Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment.

Authors:  D Burnett; R A Stockley
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

10.  Cathepsin B-like cysteine proteinase activity in sputum and immunohistologic identification of cathepsin B in alveolar macrophages.

Authors:  D Burnett; J Crocker; R A Stockley
Journal:  Am Rev Respir Dis       Date:  1983-11
View more
  39 in total

1.  Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice.

Authors:  Fusanori Nishimura; Hisa Naruishi; Koji Naruishi; Teruo Yamada; Junzo Sasaki; Christoph Peters; Yasuo Uchiyama; Yoji Murayama
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  An approach to computer-aided inhibitor design: application to cathepsin L.

Authors:  S Sudarsanam; G D Virca; C J March; S Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

3.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

4.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

Review 5.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

6.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

Authors:  G Murphy; M I Cockett; R V Ward; A J Docherty
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

7.  Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.

Authors:  Dhivya R Sudhan; Maria B Rabaglino; Charles E Wood; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2016-04-07       Impact factor: 5.150

8.  Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.

Authors:  D Brömme; A Schierhorn; H Kirschke; B Wiederanders; A Barth; S Fittkau; H U Demuth
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

9.  Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.

Authors:  Q Nguyen; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

Review 10.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.